Iridium Network: First to Use RayCare and TrueBeam Together
Iridium Network Achieves a Milestone with RayCare and TrueBeam
Iridium Network has made headlines by becoming the first center in the world to successfully use RaySearch's oncology information system, RayCare®, along with the Varian TrueBeam® linear accelerator for patient treatment. This remarkable achievement highlights the network's dedication to providing advanced cancer care to its patients.
About Iridium Network
Established in 2006, Iridium Network has rapidly evolved into the largest radiotherapy network in its region, focusing on specialized radiation oncology services. With ten TrueBeam linear accelerators deployed across four locations, the network treats over 6,000 patients annually, establishing itself as a center of excellence in cancer treatment.
The Evolution of RayCare
Iridium Network's collaboration with RaySearch spans several years, beginning when it partnered as a clinical affiliate in 2015. The network significantly influenced the development of RayCare, and by 2018, it became the first institution to clinically implement RayCare merely months after it was released to the public. This progressive approach positioned Iridium Network as a leader in oncology care.
Clinical Achievements
Recently, the interoperability certificate between RayCare 2024A and the TrueBeam family of linear accelerators was issued, confirming the seamless integration of these technologies. This milestone reinforces Iridium Network's commitment to providing state-of-the-art medical solutions and showcases its role in advancing cancer treatment methodologies.
Insights from Medical Professionals
Dr. Piet Dirix, a Radiation Oncologist at Iridium Network, spoke of the excitement surrounding the development of RayCare. He stated, "Our team is thrilled to have participated in developing RayCare, which serves as a comprehensive oncology information system that integrates all aspects of cancer care. Our goal is to streamline oncology workflows, enhancing the experience for patients and healthcare providers alike."
Driving Innovations in Cancer Care
Prof. Dirk Verellen, Director of Medical Physics at Iridium Network, emphasized that RayCare fosters consistency and automation in patient care. "This system is pivotal for maintaining high standards of patient safety, treatment efficiency, and overall care quality. We are committed to delivering pioneering radiation oncology therapies while prioritizing patient outcomes," he added.
A Partnership for Progress
Johan Löf, Founder and CEO of RaySearch, praised the collaborative efforts between RaySearch and Iridium Network. He remarked, "RayCare is a testament to the strength of our partnership with clinical experts in shaping an integrated oncology information system. Connecting RayCare with TrueBeam today underscores our shared commitment to enhancing cancer care with a focus on the patient. This is indeed a landmark moment for both organizations."
Get in Touch for More Information
For further insights and details about the innovative work at Iridium Network and RaySearch Laboratories, please reach out to:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
Frequently Asked Questions
What is RayCare?
RayCare is an advanced oncology information system developed by RaySearch Laboratories, designed to improve workflows and integrate various cancer care disciplines.
What is the TrueBeam system?
TrueBeam is a state-of-the-art linear accelerator used in radiation therapy, capable of delivering highly precise treatments to cancer patients.
Why is Iridium Network significant?
Iridium Network is the largest radiotherapy network in its area and is recognized for its innovative treatment approaches and collaborations with RaySearch.
How does RayCare enhance patient care?
RayCare improves consistency and automation, leading to better patient safety, efficiency, and quality of care in oncology settings.
Who should I contact for more information?
For inquiries, contact Johan Löf at RaySearch Laboratories via the provided email or telephone number.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- The Ensign Group Expands Portfolio with New Kansas Facility
- Blackwell 3D Advances Corporate Growth and Asian Expansion Plans
- LanzaTech Partners with SEKISUI for Waste-to-Ethanol Innovation
- RadNet, Inc. to Present at an Upcoming Healthcare Conference
- Ensign Group Expands Reach with Seven New Facilities in Colorado
- Join the Class Action Against Lululemon Athletica Inc. Today
- NANO Nuclear Energy Inc. Class Action Lawsuit Update for Investors
- Class Action Lawsuit Notice for SeaStar Medical Investors
- Symbotic Inc. Investors Alert: Class Action Lawsuit Notice
- Current Legal Action Against Stellantis N.V. Investors - STLA
- Legal Action Initiated for Ford Motor Company (F) Investors
- Markets Responding to Harris Opposition on U.S. Steel Deal
- Pakistan's PM Focuses on IMF Loan Program Completion Steps
- Orthofix Medical Inc. Faces Class Action: Important Investor Update
- MacroGenics, Inc. Investors Encouraged to Contact Legal Team
- Top Value Stocks for a Stronger Q3 Performance Ahead
- Levi & Korsinsky Urges Investors in Walgreens - Act Before Deadline
- Rolls-Royce Stock Rises Amid Cathay Pacific Engine Review
- Seritage Growth Properties Investors Alert: Class Action Lawsuit Update
- Barclays Upgrades Deutsche Bank to Overweight Amid Optimism
- Class Action Alert: MongoDB Investors Urged to Act Before Deadline
- Bitcoin's Recent Surge: Economic Data and Fed Decisions Ahead
- US Dollar Response to ISM Survey and Global Economic Factors
- Investors Urged to Join Class Action Against Sprinklr, Inc. (CXM)
- Investing in the Future: AI Stocks to Consider Now
Recent Articles
- Join the Class Action Against Indivior PLC (INDV) Now
- Clearlake Capital Expands Global Private Credit with MV Credit Acquisition
- IFS assyst Achieves Leader Status in GigaOm ITSM Radar
- Market Insights for September: Economic Trends to Watch
- GC Biopharma Partners with Hanmi to Advance Fabry Treatment
- Valmet Sets Schedule for Financial Reporting in 2025
- Aker BP Launches Oil Production from Tyrving Field
- Crédit Agricole Assurances Reveals Tender Offers and New Issue
- Tesla Announces Plans for Six-Seat Model Y Production
- Tesla to Launch Six-Seat Model Y in China by Late 2025
- Teleperformance India Wins Frost & Sullivan Customer Value Award
- Russia Stocks Decline as MOEX Russia Hits New Low
- Collagen Market Growth to Reach $13.14 Billion by 2033
- High-Integrity Pressure Protection Systems Growth Insights
- Wealth Management Strategies from Everyday Millionaires
- Automotive Ambient Lighting Market on Track for USD 12.5B
- Dividend Kings: Investing in Stability and Growth
- Alliance Trust PLC Announces Share Purchase Update
- Hewlett Packard's Ongoing Pursuit of Late Executive's Estate
- Boussard & Gavaudan Holding Limited: Estimated NAV Update
- RCI Banque Releases Consolidated Financial Statements
- Artificial Intelligence Market Forecast to Reach $3,680.47 Bn
- Investing Insights: Navitas Semiconductor's Growth Potential
- Brazil's Economic Growth Remains Resilient Amid Challenges
- Sify Achieves NVIDIA DGX-Ready Certification for AI